One of the key advantages of T-VEC is its ability to target cancer cells specifically, minimizing damage to healthy tissue. Additionally, its ability to stimulate an immune response can lead to systemic anti-tumor effects, potentially addressing metastatic disease that has spread beyond the primary tumor site.
